Improving the clinical patency of prosthetic vascular and coronary bypass grafts: The role of seeding and tissue engineering

Artificial Organs

Volumn 26, Issue 4, 2002, Pages 307-320

  Seifalian, Alexander M ^a,b   Tiwari, Alok ^a   Hamilton, George ^a   Salacinski, Henryk J ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

Cardiovascular; Coronary bypass grafts; Endothelium; Hybrid artificial organ; Mesothelium; Seeding; Tissue engineering; Vascular bypass grafts

Indexed keywords

ARTIFICIAL HEART; ENDOTHELIAL CELLS; GRAFTS; HEART; TISSUE;

BYPASS GRAFT; CARDIOVASCULAR; CORONARY BYPASS; CORONARY BYPASS GRAFT; ENDOTHELIUM; HYBRID ARTIFICIAL ORGAN; MESOTHELIUM; SEEDING; TISSUES ENGINEERINGS; VASCULAR BYPASS GRAFT;

TISSUE ENGINEERING;

BIOMATERIAL;

ALLOGRAFT; ARTICLE; AUTOGRAFT; BLOOD VESSEL PROSTHESIS; CELL ADHESION; CLINICAL TRIAL; CORONARY ARTERY BYPASS GRAFT; ENDOTHELIUM CELL; GENETIC ENGINEERING; GRAFT OCCLUSION; HUMAN; HYBRID; NONHUMAN; PRIORITY JOURNAL; PROSTHESIOLOGY; TECHNIQUE; TISSUE ENGINEERING; VEIN GRAFT; XENOGRAFT;

EID: 0036239873     PISSN: 0160564X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-1594.2002.06841.x     Document Type: Article

References (197)

1. Fate of the contralateral leg after infrainguinal bypass
2. Lower extremity arterial reconstruction in the very elderly: Successful outcome preserves not only the limb but also residential status and ambulatory function
3. Infrainguinal arterial reconstruction for claudication: Is it worth the risk? An analysis of 409 procedures
4. Aortocoronary saphenous vein graft disease: Pathogenesis, predisposition, and prevention
5. Use of internal mammary artery for emergency grafting after failed coronary angioplasty
6. Saphenous vein graft failure: Etiologic considerations and strategies for prevention
7. A comparative study of alternative conduits for lower extremity revascularization: All-autogenous conduit versus prosthetic grafts
8. Arm vein conduit is superior to composite prostheticautogenous grafts in lower extremity revascularization
9. Choice of material for above-knee femoropopliteal bypass graft
10. Preoperative saphenous venography in arterial reconstructive surgery of the lower extremity
11. Randomization of autogenous vein and polytetrafluorethylene grafts in femoral-distal reconstruction
12. Development of intimal hyperplasia in six different vascular prostheses
13. The role of platelets, thrombin and hyperplasia in restenosis after coronary angioplasty
14. Effect of compliance mismatch on vascular graft patency
15. Compliance properties of conduits used in vascular reconstruction
16. The mechanical behavior of vascular grafts: A review
17. Healing of arterial prosthesis in man: Its incompleteness
18. The role of endothelium in cardiovascular homeostasis and diseases
19. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine
20. Cultured bovine aortic endothelial cells secrete factor(s) chemotactic for aortic smooth muscle cells
21. Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis
22. Migration of smooth muscle and endothelial cells. Critical events in restenosis
23. A single-staged technique for seeding vascular grafts with autogenous endothelium
24. Endothelial cell seeding of polytetrafluoroethylene vascular grafts in humans: A preliminary report
25. Clinical autologous in vitro endothelialization of infrainguinal ePTFE grafts in 100 patients: A 9-year experience
26. Comparative in vitro evaluation of two different preparations of small diameter polyurethane vascular grafts
27. New prostheses for use in bypass grafts with special emphasis on polyurethanes
28. Segmented polyurethane: A polyether polymer. An initial evaluation for biomedical applications
29. Optimal endothelialization of a new compliant poly (carbonate-urea)urethane vascular graft with effect of physiological shear stress
30. Effect of prolonged pulsatile shear stress in vitro on endothelial cell seeded PTFE and compliant polyurethane vascular grafts
31. A hybrid compliant vascular graft seeded with microvascular endothelial cells extracted from human omentum
32. A two year study of the performance of a small diameter polyurethane (Biomer) arterial prosthesis
33. Polyurethane vascular prostheses decreases neointimal formation compared with expanded polytetrafluoroethylene
34. Surface fissuring of polyurethanes following in vivo exposure
35. In vitro stability of a novel compliant poly (carbonate-urea)urethane to oxidative and hydrolytic stress
36. ESCA surface characterization of four IUPAC reference polymers
37. Presence of endothelium in an axillary femoral graft of knitted Dacron with an external velour surface
38. A new method to give an antithrombogenicity to biological materials and its successful application to vascular grafts
39. In situ cannulation, microgrid follow-up and low-density plating provide first passage endothelial cell mass cultures for in vitro lining
40. Tissue engineering of vascular bypass grafts: Role of endothelial cell extraction
41. Patency and morphology of fibrous polyurethane vascular prostheses implanted in the femoral artery of dogs after seeding with subcultivated endothelial cells
42. Improved endothelial cell seeding with cultured cells and fibronectin-coated grafts
43. Improved in vivo endothelialization of prosthetic grafts by surface modification with fibronectin
44. Extracellular matrix preparation of expanded polytetrafluoroethylene grafts seeded with endothelial cells: Influence on early platelet deposition, cellular growth, and luminal prostacyclin release
45. In vitro-lined endothelium: Initial integrity and ultrastructural events
46. Kinetics of endothelial cell seeding
47. Enhanced strength of endothelial attachment on polyester elastomer and polytetrafluoroethylene graft surfaces with fibronectin substrate
48. Age dependency of neointima formation on vascular prostheses in dogs
49. The vicious cycle of nonhealing neointima in fabric vascular prostheses
50. Biochemical response to Dacron vascular prosthesis
51. Some species differences in fibrinolysis and blood coagulation
52. Seeding of ePTFE carotid interposition grafts in sheep and dogs: Species-dependent results
53. Interspecies healing of porous arterial prostheses: Observations, 1960 to 1974
54. Reduced reproductive capacity of freshly harvested endothelial cells in smokers: A possible shortcoming in the success of seeding?
55. Seeding human arterial prostheses with mechanically derived endothelium. The detrimental effect of smoking
56. Enhanced patency of venous Dacron grafts by endothelial cell sodding
57. Clinical experience with autologous endothelial cell-seeded polytetrafluoroethylene coronary artery bypass grafts
58. Use of freshly isolated capillary endothelial cells for the immediate establishment of a monolayer on a vascular graft at surgery
59. Microvascular endothelial cells from human omental tissue: Modified method for long-term cultivation and new aspects of characterization
60. Seeding arterial prostheses with vascular endothelium. The nature of the lining
61. Enhanced patency of small-diameter, externally supported Dacron iliofemoral grafts seeded with endothelial cells
62. Endothelial cell seeding of small-diameter vascular grafts
63. Endothelial cell-seeded four-millimeter Dacron vascular grafts: Effects of blood flow manipulation through the grafts
64. Impact of endothelial cell seeding on long-term patency and subendothelial proliferation in a small-caliber highly porous polytetrafluoroethylene graft
65. Immediate seeding of enzymatically derived endothelium in Dacron vascular grafts. Early experimental studies with autologous canine cells
66. In vivo experiments with mesothelial cell seeded ePTFE vascular grafts
67. Endothelium develops on seeded human arterial prosthesis: A brief clinical note
68. Endothelial seeding of polytetrafluoroethylene popliteal bypasses. A preliminary report
69. Reduction in deposition of indium 111-labeled platelets after autologous endothelial cell seeding of Dacron aortic bifurcation grafts in humans: A preliminary report
70. Reduced platelet deposition on seeded versus unseeded segments of expanded polytetrafluoroethylene grafts: Clinical observations after a 6-month follow-up
71. Endothelial cell seeding reduces thrombogenicity of Dacron grafts in humans
72. Endothelial cell seeded Dacron aortobifurcated grafts: Platelet deposition and long-term follow-up
73. Endothelial seeding of polytetrafluoroethylene femoral popliteal bypasses: The failure of low-density seeding to improve patency
74. Fibrinolysis profiles and platelet activation after endothelial cell seeding of prosthetic vascular grafts
75. Delayed exposure to pulsatile shear stress improves retention of human saphenous vein endothelial cells on seeded ePTFE grafts
76. In vitro endothelialization of small-caliber vascular grafts
77. Human microvessel endothelial cell isolation and vascular graft sodding in the operating room
78. Lower extremity revascularization with polytetrafluoroethylene grafts seeded with microvascular endothelial cells
79. Isolation and characterization of microvessel endothelial cells from human mammary adipose tissue
80. Electron microscopic and immunocytochemical profiles of human subcutaneous fat tissue microvascular endothelial cells
81. Pericardial cells for graft seeding: Isolation, culture and identification
82. Endothelial cell transplantation
83. Human clinical trials of microvascular endothelial cell sodding
84. A cobblestone cell isolated from the human omentum: The mesothelial cell: Isolation, identification, and growth characteristics
85. Endothelialization of vascular prosthetic surfaces after seeding or sodding with human microvascular endothelial cells
86. Human omental microvascular endothelial and mesothelial cells: Characterization of two distinct mesodermally derived epithelial cells
87. 111In oxine
88. Implantation of in vitro endothelialized polytetrafluoroethylene grafts in human beings. A preliminary report
89. Prospective clinical study with in vitro endothelial cell lining of expanded polytetrafluoroethylene grafts in crural repeat reconstruction
90. Seeding of intravascular stents with genetically engineered endothelial cells
91. Genetically engineered endothelial cells remain adherent and viable after stent deployment and exposure to flow in vitro
92. Seeding of intravascular stents by the xenotransplantation of genetically modified endothelial cells
93. Seeding of intracoronary stents with immortalized human microvascular endothelial cells
94. Human endothelial cell cultures from progenitor cells obtained by leukapheresis
95. Fat- and bone marrow-impregnated small diameter PTFE grafts
96. Isolation of endothelial cells and their progenitor cells from human peripheral blood
97. Enhanced endothelialization and microvessel formation in polyester grafts seeded with CD34 (+) bone marrow cells
98. Choice, isolation, and preparation of cells for bioartificial vascular grafts
99. Development of regenerative cardiomyocytes from mesenchymal stem cells for cardiovascular tissue engineering
100. In vitro endothelialization of commercially available heart valve bioprostheses with cultured adult human cells
101. Endothelialization of mechanical heart valves in vitro with cultured adult human cells
102. Tissue engineering heart valves: Valve leaflet replacement study in a lamb model
103. Tissue-engineered heart valves. Autologous valve leaflet replacement study in a lamb model
104. Implantation of vascular grafts lined with genetically modified endothelial cells
105. eNOS-overexpressing endothelial cells inhibit platelet aggregation and smooth muscle cell proliferation in vitro
106. In vivo retention of endothelial cells adenovirally transduced with tissue-type plasminogen activator and seeded onto expanded polytetrafluoroethylene
107. Seeding of vascular grafts with genetically modified endothelial cells. Secretion of recombinant TPA results in decreased seeded cell retention in vitro and in vivo
108. Improved adherence of genetically modified endothelial cells to small-diameter expanded polytetrafluoroethylene grafts in a canine model
109. Vascular gene therapy in the 21st century
110. Improving the interface between biomaterials and the blood. The gene therapy approach
111. Cellular engineering of vascular bypass grafts: Role of chemical coatings for enhancing endothelial cell attachment
112. Endothelialization of crosslinked albumin-heparin gels
113. Adherence and proliferation of endothelial cells on surface-immobilized albumin-heparin conjugate
114. Proliferation of endothelial cells on surface-immobilized albumin-heparin conjugate loaded with basic fibroblast growth factor
115. A honeycomb collagen carrier for cell culture as a tissue engineering scaffold
116. Endothelialization of human collagen surfaces with human adult endothelial cells
117. Attachment of indium-111 labeled endothelial cells to pretreated polytetrafluoroethylene vascular grafts
118. An experimental collagen-impregnated Dacron graft: Potential for endothelial seeding
119. Endothelial cell seeding on different polyurethanes
120. Comparison of epoxides on grafting collagen to polyurethane and their effects on cellular growth
121. Precoating substrate and surface configuration determine adherence and spreading of seeded endothelial cells on polytetrafluoroethylene grafts
122. Endothelial cell behavior on vascular prosthetic grafts: Effect of polymer chemistry, surface structure, and surface treatment
123. Improved patency of collagen-impregnated grafts after in vitro autogenous endothelial cell seeding
124. Endothelial seeding of compliant polyurethane vascular graft material
125. Preparation and characterization of collagen-elastin matrices from blood vessels intended as small diameter vascular grafts
126. Improving endothelial cell adhesion to vascular graft surfaces: Clinical need and strategies
127. The effect of varying fibronectin concentration on the attachment of endothelial cells to polytetrafluoroethylene vascular grafts
128. Fibronectin binding to gelatin-impregnated Dacron (Gelseal) prostheses
129. Seeding of enzymatically derived and subcultivated canine endothelial cells on fibrous polyurethane vascular prostheses
130. Adhesion and stability of fibronectin on PTFE before and after seeding with normal and synchronized endothelial cells: In vitro study
131. Optimal seeding conditions for human endothelial cells
132. Human vascular endothelial cells on expanded PTFE precoated with an engineered protein adhesion factor
133. A comparison between fibronectin and Matrigel pretreated ePTFE vascular grafts
134. The effect of fibronectin coating on endothelial cell kinetics in polytetrafluoroethylene grafts
135. Use of tritiated thymidine as a marker to compare the effects of matrix proteins on adult human vascular endothelial cell attachment: Implications for seeding of vascular prostheses
136. An improved method for endothelial cell seeding on polytetrafluoroethylene small caliber vascular grafts
137. Substrate effects on endothelial cell adherence rates
138. Cell seeding for small diameter ePTFE vascular grafts: A comparison between adult human endothelial and mesothelial cells
139. Adult human endothelial cell seeding using expanded polytetrafluoroethylene vascular grafts: A comparison of four substrates
140. New evidence and new hope concerning endothelial seeding of vascular grafts
141. Scaffold precoating with human autologous extracellular matrix for improved cell attachment in cardiovascular tissue engineering
142. Performance of a polyurethane vascular prosthesis carrying a dipyridamole (Persantin) coating on its lumenal surface
143. Cell adhesion peptide modification of gold-coated polyurethanes for vascular endothelial cell adhesion
144. Fibrin glue as matrix for cultured autologous urothelial cells in urethral reconstruction
145. Seeding of human microvascular endothelial cells onto polytetrafluoroethylene graft material
146. Serum proteins provide a matrix for cultured endothelial cells on expanded polytetrafluoroethylene vascular grafts
147. Use of plasma glow for surface-engineering biomolecules to enhance bloodcompatibility of Dacron and PTFE vascular prosthesis
148. An assessment of elastomers for biomedical applications
149. Blood interfacing implants
150. Improved endothelial cell attachment on ePTFE vascular grafts pretreated with synthetic RGD-containing peptides
151. Endothelial cell seeding of de-endothelialized human arteries: Improvement by adhesion molecule induction and flow-seeding technology
152. Effectiveness of fragmented autologous adipose tissue as a sealer of porous textile grafts: Effect on endothelial development
153. Sealing of a fabric vascular prosthesis with autologous adipose tissue: A preliminary report of its clinical application
154. Transplantation of autologous tissue fragments into an e-PTFE graft with long fibrils
155. Sealing of highly porous fabric vascular prostheses by adipose connective tissue fragments instead of preclotting with fresh blood
156. Rapid endothelialization of vascular prostheses by seeding autologous venous tissue fragments
157. Clinical long-term results of vascular prosthesis sealed with fragmented autologous adipose tissue
158. Options for right ventricular outflow tract reconstruction
159. Tissue engineering of vascular grafts: Human cell seeding of decellularized porcine matrix
160. Early rupture and degeneration of cryopreserved arterial allografts
161. Let's understand nature better: De- and regeneration of autologous and artificial small caliber vascular grafts
162. New alternative coronary bypass graft: First clinical experience with an autologous endothelialized cryopreserved allograft
163. Acellular matrix: A biomaterials approach for coronary artery bypass and heart valve replacement
164. Improving vascular grafts: The importance of mechanical and hemodynamic properties
165. Biomaterial-microvasculature interactions
166. Vascular tissue engineering: Designer arteries
167. Functional arteries grown in vitro
168. An integrated approach to the design and engineering of hybrid arterial prostheses
169. Endothelial cell adherence to small intestinal submucosa: An acellular bioscaffold
170. Quantification of the fiber architecture and biaxial mechanical behavior of porcine intestinal submucosa
171. Mechanical evaluation and design of a multilayered collagenous repair biomaterial
172. Combining chondrocytes and smooth muscle cells to engineer hybrid soft tissue constructs
173. A blood vessel model constructed from collagen and cultured vascular cells
174. Highly oriented, tubular hybrid vascular tissue for a low pressure circulatory system
175. In vitro construction of a human blood vessel from cultured vascular cells: A morphologic study
176. A completely biological tissue-engineered human blood vessel
177. Novel vascular graft grown within recipient's own peritoneal cavity
178. Engineering of human vascular aortic tissue based on a xenogenic starter matrix
179. Venous reconstruction using hybrid vascular tissue composed of vascular cells and collagen: Tissue regeneration process
180. Self-organized, tubular hybrid vascular tissue composed of vascular cells and collagen for low-pressure-loaded venous system
181. Fabrication of branched hybrid vascular prostheses
182. Microfabricated surface designs for cell culture and diagnosis
183. Reconstruction of a hybrid vascular graft hierarchically layered with three cell types
184. Significance of porosity and compliance of microporous, polyurethane-based microarterial vessel on neoarterial wall regeneration
185. An in vitro endothelialized compliant vascular graft minimizing hyperplasia
186. Enhanced vascularization in a microporous polyurethane graft impregnated with basic fibroblast growth factor and heparin
187. Tissue engineering of vascular grafts
188. Tissue engineering of autologous aorta using a new biodegradable polymer
189. Bioengineered cardiac grafts: A new approach to repair the infarcted myocardium?
190. Staged growth of optimized arterial model trees
191. The artificial artery
192. Transplantation of a tissue-engineered pulmonary artery
193. Optimized growth conditions for tissue engineering of human cardiovascular structures
194. Acellular vascular tissues: Natural biomaterials for tissue repair and tissue engineering
195. Tissue engineering in cardiovascular surgery: New approach to develop completely human autologous tissue
196. Directions in cardiovascular tissue engineering
197. Dreams for the future in the field of in vivo tissue engineering